rs3738198 — SLC30A1 ZnT1 variant

SLC30A1 rs3738198 — An Intronic Variant in the Primary Zinc Export Gateway

Every milligram of dietary zinc that enters systemic circulation must first cross the basolateral membrane of an intestinal enterocyte. Only one protein manages that crossing at scale: ZnT1¹¹ ZnT1
Zinc Transporter 1, the product of SLC30A1 on chromosome 1q32.3; ubiquitously expressed, plasma-membrane localised, the dominant zinc efflux pump in most mammalian cell types. Without functional ZnT1, dietary zinc accumulates inside the enterocyte and never reaches the portal vein. The knockout phenotype in mice is lethal within weeks — a fact that underscores just how central this single protein is to whole-body zinc supply.

rs3738198 is an intronic variant (GRCh38 chromosome 1, position 211,576,392; G>C on the plus strand, C>G on the coding minus strand) lying within an intron of SLC30A1. The minor C allele (plus-strand) is present in roughly 13–15% of all chromosomes globally, with higher frequency in African (~22%) and East Asian (~20%) populations than in Europeans (~11%). No clinical significance entry exists in ClinVar, and no published study has directly tested this rsid in a phenotypic association study. Its biological plausibility rests on the gene's established, essential role in zinc homeostasis and the observation that SLC30A1 expression is exquisitely sensitive to regulatory inputs — making intronic regulatory variants a plausible source of inter-individual variability in zinc absorption efficiency.

The Mechanism

SLC30A1 encodes a homodimeric six-transmembrane-helix zinc transporter that coordinates zinc at two binding sites (Z1 and Z2) within the transmembrane core. Mutations at the Z2 site produce the most robust reductions in zinc export capacity, consistent with Z2 being the primary zinc-translocation interface²² Mutations at the Z2 site produce the most robust reductions in zinc export capacity, consistent with Z2 being the primary zinc-translocation interface. The protein is localised to the basolateral membrane of intestinal epithelial cells, the plasma and lysosomal membranes of macrophages, and the neuronal plasma membrane — wherever cells need to expel excess cytosolic zinc.

Gene expression is driven through two metal-response element (MRE) sequences in the SLC30A1 promoter. When intracellular zinc rises, the transcription factor MTF-1³³ MTF-1
Metal-regulatory transcription factor 1; the master zinc sensor that activates metallothionein and ZnT1 genes in response to cytosolic zinc elevation translocates to the nucleus and induces ZnT1 mRNA up to 12-fold within 3 hours. Conversely, dietary zinc deficiency down-regulates ZnT1 expression by ~40% to help cells retain zinc. An intronic variant like rs3738198 could influence this regulatory dynamic by altering splicing efficiency, intronic enhancer activity, or chromatin accessibility near MTF-1 binding sites — mechanisms that have not been specifically studied at this locus but are well-established for intronic variants at other transporter genes.

The Evidence

Gene essentiality: The most direct evidence for ZnT1's importance comes from mouse models. Ruaud et al. (2024)⁴⁴ Ruaud et al. (2024) showed that inducible intestinal-specific Slc30a1 knockout mice die within two weeks of gene deletion, with serum zinc crashing, intestinal barrier disruption, and massive inflammatory activation. Systemic zinc injection fully rescued all animals. This establishes intestinal SLC30A1 as the non-redundant gate for dietary zinc delivery.

Somatic mutations and ion selectivity: A 2023 Nature Genetics study by Nanba et al.⁵⁵ Nanba et al. identified recurrent in-frame deletions at the His43/Asp47 zinc-binding site in SLC30A1 as the driver of aldosterone-producing adenomas through gain-of-function sodium influx. While these are somatic coding mutations — distinct from the germline intronic rs3738198 — they demonstrate that even small structural changes near the zinc-binding site substantially alter ion transport selectivity, and that ZnT1 function is exquisitely sensitive to perturbation.

Immune zinc mobilisation: Stocks et al. (2021)⁶⁶ Stocks et al. (2021) showed that LPS-induced SLC30A1 in human macrophages delivers zinc into vesicular compartments around intracellular bacteria, creating a toxic zinc microenvironment that limits bacterial growth. This links ZnT1 not only to nutritional zinc supply but to the front line of innate immune defence.

Direct rs3738198 evidence: No published study has tested this specific intronic rsid for phenotypic association with serum zinc, immune function, or other outcomes. The evidence level for this variant specifically is accordingly emerging — biologically plausible, mechanistically grounded, but lacking direct human genetic evidence for phenotypic effect.

Practical Actions

Because rs3738198 is an intronic variant with no direct phenotypic evidence, practical guidance is drawn from the broader biology of ZnT1 and zinc homeostasis rather than from genotype-specific outcome data. The core idea is that anyone with a haplotype that may modestly reduce basolateral zinc export efficiency should ensure their dietary zinc supply is robust, use forms with higher bioavailability, and monitor for functional zinc inadequacy — recognising that the degree of risk from this specific variant alone is uncertain.

Zinc bioavailability from food varies dramatically: meat-source zinc (with animal proteins that enhance absorption) reaches 25–40% absorption efficiency, while phytate- rich plant sources (legumes, wholegrains) yield 10–15%. For someone whose intestinal ZnT1 may be at reduced capacity, optimising the bioavailability of dietary zinc provides a margin of safety without requiring supplementation.

Interactions

With SLC30A8 (ZnT8): SLC30A8 controls zinc secretion into insulin vesicles in pancreatic beta cells. While ZnT1 and ZnT8 operate in different tissues and contexts, their combined genetic load is relevant to understanding whole-body zinc distribution. Individuals carrying modestly reduced function in both a systemic zinc exporter (ZnT1/SLC30A1) and a tissue-specific zinc sequestrant (ZnT8/SLC30A8) may have atypical zinc partitioning between compartments.

With dietary zinc and phytate: The zinc-sensing MTF-1/ZnT1 axis is responsive to dietary zinc status. High-phytate diets that reduce zinc absorption will exacerbate any baseline reduction in ZnT1 export capacity, while zinc-adequate diets from high-bioavailability sources compensate. This gene-diet interaction is the primary lever available to C-allele carriers at this locus.